Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidenori Hara

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery|September 15, 2004
[Traumatic lung injury]Hidenori Hara, Hirokuni Yoshimura
Asian Cardiovascular & Thoracic Annals|February 27, 2014
Risk factors for postoperative complications in the elderly with lung cancerFumihiro Ogawa, Guoqin Wang, Yoshio Matsui, et al.
General Thoracic and Cardiovascular Surgery|September 26, 2009
Clinical report on a computer-controlled hand-actuated stapling system for general lung surgery: the first application in JapanYukitoshi Satoh, Yoshio Matsui, Fumihiro Ogawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis CMasato Igarashi, Takeshi Suda, Hidenori Hara, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung diseaseAkira Iyoda, Shi-Xu Jiang, Hideki Amano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[A Case of Hepatic Oligometastasis from Distal Bile Duct Cancer Treated with Laparoscopic Surgery Five Years after Pancreatoduodenectomy]Megumu Watabe, Shintaro Yamazaki, Mitsuo Suda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2003
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesisKenta Suzuki, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences|February 12, 2002
Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patientsMitsuhiro Takimoto, Shogo Ohkoshi, Takafumi Ichida, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Kyobu Geka. the Japanese Journal of Thoracic Surgery|September 15, 2004
[Traumatic lung injury]Hidenori Hara, Hirokuni Yoshimura
Asian Cardiovascular & Thoracic Annals|February 27, 2014
Risk factors for postoperative complications in the elderly with lung cancerFumihiro Ogawa, Guoqin Wang, Yoshio Matsui, et al.
General Thoracic and Cardiovascular Surgery|September 26, 2009
Clinical report on a computer-controlled hand-actuated stapling system for general lung surgery: the first application in JapanYukitoshi Satoh, Yoshio Matsui, Fumihiro Ogawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis CMasato Igarashi, Takeshi Suda, Hidenori Hara, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung diseaseAkira Iyoda, Shi-Xu Jiang, Hideki Amano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[A Case of Hepatic Oligometastasis from Distal Bile Duct Cancer Treated with Laparoscopic Surgery Five Years after Pancreatoduodenectomy]Megumu Watabe, Shintaro Yamazaki, Mitsuo Suda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2003
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesisKenta Suzuki, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences|February 12, 2002
Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patientsMitsuhiro Takimoto, Shogo Ohkoshi, Takafumi Ichida, et al.
Pageof 1